Daoyuan Li

Title: Daoyuan Li: Innovator in Pharmaceutical Composition

Introduction

Daoyuan Li is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.

Latest Patents

Li holds a patent for a composition comprising aflibercept and a variant thereof. This composition includes a truncation variant with a truncated VEGF binding portion of aflibercept, where the content of the truncation variant is less than or equal to about 20% by mass percentage. Additionally, the patent outlines a pharmaceutical formulation that incorporates this composition. It also provides methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products. This patent showcases his expertise and commitment to advancing pharmaceutical science. He has 1 patent to his name.

Career Highlights

Daoyuan Li is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work at Qilu has allowed him to focus on innovative drug formulations and contribute to the development of effective therapeutic solutions.

Collaborations

Li collaborates with esteemed colleagues, including Yue Yu and Guijiang Wang. These partnerships enhance the research and development efforts within the company, fostering an environment of innovation and creativity.

Conclusion

Daoyuan Li's contributions to pharmaceutical compositions reflect his dedication to improving healthcare solutions. His innovative work continues to impact the industry positively.